Trials / Completed
CompletedNCT05700747
Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- MGH Institute of Health Professions · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore whether a structured program can help reduce the challenges of decreased physical functioning and quality of life for participants with multiple myeloma by providing a customized exercise program and fostering engagement in meaningful activities. The name of the study intervention involved in this study is: Health Through Activity (HTA) (six-session, rehabilitation exercise regimen)
Detailed description
The goal of this single arm, pilot study of the Health Through Activity (HTA) rehabilitation intervention for people living with multiple myeloma is to determine if investigators can feasibly deliver the program out of the IMPACT Practice Center at the MGH Institute for Health Professions. \- The six-session 'Health Through Activity' program provides a customized exercise plan and encourages engagement in activities to reduce disability and improve quality of life. * Study procedures including screening for eligibility, in-clinic visits, questionnaires, and surveys. * Participation in this research study is expected to last up to 4 months. It is expected that up to 20 people will take part in this research study. An internal grant from the Massachusetts General Hospital Institute of Health Professions is providing equipment and staffing for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Health Through Activity | Six, weekly, customized sessions with licensed physical and occupational therapists. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2025-03-28
- Completion
- 2025-03-28
- First posted
- 2023-01-26
- Last updated
- 2025-12-16
- Results posted
- 2025-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05700747. Inclusion in this directory is not an endorsement.